Loading issuer details...
How Promisia Healthcare Limited makes money — FY2025
Revenue $31.1m · EBITDA $4.2m (13.5% of revenue) · Net profit $6.8m (22.0% of revenue)
Band widths are proportional to NZD amounts. Dashed outlines mark derived figures; the hatched node is a balancing item (net profit less every line above it).
| FY2025 | Amount | Status | Note |
|---|---|---|---|
| Revenue | $31.1m | Reported | |
| Operating costs (net of other income) | −$26.9m | Derived * | Reported operating expenses $23.9m do not reconcile; not used. |
| EBITDA | $4.2m | Reported | |
| Depreciation & amortisation | −$409k | Reported | |
| EBIT | $3.8m | Reported | |
| Interest (net finance costs) | −$2.9m | Reported | |
| Income tax | −$107k | Reported | |
| Other items (net gain) | +$6.1m | Balancing item * | Net profit less the lines above; covers fair-value movements, impairments, associates and anything else not itemised. |
| Net profit | $6.8m | Reported |
- * operating costs: $26.9m = Revenue − EBITDA
Figures extracted automatically from the annual report; check against the report. NZD thousands as stored, shown in millions. Source: annual_report_pdf · method: claude_haiku_pdf · extracted 7 March 2026.
Annual report: Promisia Healthcare Limited Annual Report (PDF, NZX)
Promisia Healthcare Limited board of directors
5 current directors, 80% independent, average tenure 4.1 years.
| Director | Role | Independent | Appointed | Tenure | Committees |
|---|---|---|---|---|---|
| Rhonda Sherriff | Chair | Yes | 2025 | 1.2 yrs | Audit & Risk Committee (Chair) |
| Tony Mortensen | Independent Director | Yes | 2025 | 1.2 yrs | Audit & Risk Committee (Chair) |
| Thomas Brankin | Executive Director | No | 2013 | 13.5 yrs | — |
| Craig Percy | Independent Director | Yes | 2025 | 1.4 yrs | — |
| Jill E Hatchwell | Independent Director | Yes | 2023 | 3.2 yrs | Audit & Risk Committee (Chair) |
PHL governance score breakdown
Promisia Healthcare Limited scores 91/100 (Excellent) on the NZXplorer Governance Risk Score for FY2026, based on 73% data coverage. See the GRS methodology.
- Board structure
- 24/25
- Shareholder rights
- 20/20
- Executive remuneration
- 7.5/10
Promisia Healthcare Limited largest shareholders
Top 10 registered holders of PHL as disclosed for FY2025. Registry holdings include custodians and nominees, which may hold on behalf of many underlying investors.
| # | Holder | Holding |
|---|---|---|
| 1 | Thomas David Brankin & Michael John Kirwin Lay | 42.84% |
| 2 | Asset Management Limited | 9.51% |
| 3 | Jillian Mary O'Brien & Hamish William O'Brien & Michael James Creed | 4.14% |
| 4 | Andrew Raymond Mitchell | 3.89% |
| 5 | Donald Hamish Mackintosh | 3.40% |
| 6 | Public Trust Limited | 2.41% |
| 7 | Christchurch Treeman Limited | 1.90% |
| 8 | Derek Montgomery Daniel & Aka Trustees Limited | 1.90% |
| 9 | Jarden Custodians Limited | 1.90% |
| 10 | Stephen Underwood | 1.01% |
Recent PHL NZX announcements
The 10 most recent filings by Promisia Healthcare Limited to the NZX.
- PHL HY27 results: first dividend and upgraded guidanceHalf Year Results
- SPH Notice - Gould Holdings Limited (GHL)Substantial Holder Notice
- SPH Notice - Asset Management LimitedSubstantial Holder Notice
- Capital Change NoticeCapital Change
- Operational Update - Q2 FY27Quarterly Update
- SPH Notice - Gould Holdings Limited (GHL)Substantial Holder Notice
- SPH Notice (Shares) - Gould Holdings LimitedSubstantial Holder Notice
- Shareholder and Warrantholder SelldownGeneral
- SPH Notice - Asset Management LimitedSubstantial Holder Notice
- SPH Notice (Warrants) - Gould Holdings LimitedSubstantial Holder Notice
Promisia Healthcare Limited (PHL) — frequently asked questions
What does Promisia Healthcare Limited do?
Pushpay Holdings provides donor management, engagement, and payment solutions for faith-based organizations and nonprofits across the United States, New Zealand, and Australia. Promisia Healthcare Limited is listed on the NZX under the ticker PHL, in the Healthcare sector.
What is the Promisia Healthcare Limited (PHL) share price?
Promisia Healthcare Limited (NZX:PHL) shares closed at $0.67 on 11 November 2026, up 3.88% on the previous close. At that price its market capitalisation was about $36 million, based on 54,218,650 shares on issue.
Who are the directors of Promisia Healthcare Limited?
Promisia Healthcare Limited has 5 current directors: Rhonda Sherriff (Chair), Tony Mortensen (Independent Director), Thomas Brankin (Executive Director), Craig Percy (Independent Director) and Jill E Hatchwell (Independent Director). 4 of the 5 are recorded as independent (80%). Average board tenure is 4.1 years.
Who is the chair of Promisia Healthcare Limited?
Rhonda Sherriff chairs the Promisia Healthcare Limited board, and has been a director since 2025.
Who are the largest shareholders of Promisia Healthcare Limited?
The largest registered holder of PHL shares in the FY2025 top-20 register was Thomas David Brankin & Michael John Kirwin Lay, with 42.84%, followed by Asset Management Limited (9.51%) and Jillian Mary O'Brien & Hamish William O'Brien & Michael James Creed (4.14%).
What is Promisia Healthcare Limited's governance score?
Promisia Healthcare Limited has an NZXplorer Governance Risk Score of 91/100 (Excellent) for FY2026, based on 73% data coverage.
When was the last Promisia Healthcare Limited annual meeting?
The most recent Promisia Healthcare Limited annual meeting on record was held on 27 August 2026.
Healthcare companies on the NZX
Compare Promisia Healthcare Limited with other NZX-listed healthcare companies.